Explore more publications!

Healthy Living Europe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.

Press releases published on March 30, 2026

Artelo Biosciences Announces Closing of $11.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Harvard Journal Names Italian Street Art Festival a Global Public Health Model
ProHealth Longevity BPC‑157 Claims Evaluated: Most Effective BPC157 Peptide Brand on the Market (2026)
Jasper Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Corporate Update
Teladoc Health Appoints Susan Salka, Experienced Healthcare Executive, to Its Board of Directors
Vireo Growth Inc. Announces Effectiveness of Management Services Agreement with  PharmaCann Inc.
River Oaks Treatment Center Dedicates Its Primary Mental Health Program on World Bipolar Day
Vicarious Surgical Completes Integrated Benchtop Testing of Full Surgical Instrument Suite for Ventral Hernia Repair
BIO GREEN MED SOLUTION REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
Inventiva publie ses résultats financiers  annuels 2025 et fait le point sur son activité
Inventiva reports 2025 full year results and provides a business update
Beta Bionics to Announce First Quarter 2026 Financial Results on April 21, 2026
Sight Sciences to Present at the 25th Annual Needham Healthcare Conference on April 13th
Invivyd Announces Presentation at the World Vaccine Congress Washington
Lexeo Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
AEON Biopharma Reports Full Year 2025 Financial Results and Highlights Positive Comparative Analytical Results and FDA Feedback for ABP-450 Biosimilar Program
Nutriband Selects Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch
Solana Company Reports Fourth Quarter and Full Year 2025 Financial Results
Fortress Biotech’s Subsidiary Cyprium Therapeutics Closes Sale of Rare Pediatric Disease Priority Review Voucher for $205 Million
RenovoRx Reports Full Year 2025 Financial Results and Provides Business Update

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions